April 24, 2018 9:27 AM ET


Company Overview of IFM Therapeutics, Inc.

Key Executives for IFM Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Gary D. Glick Ph.D.20 RelationshipsCo-Founder, CEO & Director--
Luigi Franchi No RelationshipsCo-Founder--
Matthias Geyer No RelationshipsCo-Founder--
Eicke Latz 22 RelationshipsCo-Founder--
Anthony William Opipari Jr., M.D., Ph.D.No RelationshipsCo-Founder--
View More Key Executives

IFM Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Jean-François Formela 162 RelationshipsVermillion, Inc.60
Gary D. Glick Ph.D. 20 RelationshipsIFM Therapeutics, Inc.--
Diane J. Mathis Ph.D. 99 RelationshipsTempero Pharmaceuticals, Inc.--
Shelley Chu Ph.D., M.D. 33 RelationshipsAbingworth LLP--
Michael Gladstone 20 RelationshipsAtlas Venture L.P.--
View All Board Members

IFM Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Diane J. Mathis99 Relationships18 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
IFM Therapeutics, Inc. CEO Compensation
Industry Average


Kalvista Pharmaceuticals, Inc. Announces Board Changes
April 20, 2018 8:11 PM ET
Marc E. Goldberg Resigns from the Board of CohBar, Inc
April 20, 2018 8:10 PM ET
Orphan Biovitrum Names Fredrik Wetterlundh as New Head of Human Resources
April 20, 2018 6:19 PM ET
Mariola Soehngen Not to Renew Her Position as Member and Chief Executive Officer on the Board of Directors of Mologen AG Which Expires on 31 October 2018
April 20, 2018 5:14 PM ET
Exicure, Inc. Appoints Matthias G. Schroff as Chief Operating Officer
April 20, 2018 3:52 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IFM Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.